ApogeeX does not offer services to residents of certain jurisdictions, including the United States, Canada, the United Kingdom, Malaysia and others. The content of this website, including translations, should not be construed as a means of solicitation. Investors make their own and independent decisions.
Trading in CFDs and leveraged products generally involves substantial risk of loss, and you may lose all of your invested capital.
ApogeeX AU Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) with Australian Financial Services Licence number 505077 and Australian Company Number 622 536 485.
APOGEEX ZA (PTY) LTD is a Financial Services Provider registered in South Africa with registration number 2025/107571/07 and authorised by the Financial Sector Conduct Authority (FSCA) with FSP number 55273.
ApogeeX Capital (MU) Limited is an Investment Dealer registered in Mauritius with company number 238783 and authorised by the Financial Services Commission (FSC) with licence number GB26206707.
ApogeeX Capital LLC is registered in Saint Vincent and the Grenadines with registration number 4536 LLC 2026.
The entities above are duly authorised to operate under the ApogeeX brand and trademarks.
Risk Warning: Our services relate to complex derivative instruments requiring appropriate knowledge and understanding. Their prices may fluctuate rapidly and may become valueless. Trading involves a high risk of loss, with traders likely to incur losses exceeding the potential for profits. Losses may extend up to the full amount of funds in the trading account. Under no circumstances shall ApogeeX have any liability to any person or entity for any loss or damage in whole or in part caused by, resulting from, or relating to any investing activity.
The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity.
The information on this website may only be copied with the express written permission of ApogeeX.
© 2026 ApogeeX. All rights reserved.